Correlation between the total volume, transitional zone volume of the prostate, transitional prostate zone index and lower urinary tract symptoms (LUTS)

International Urology and Nephrology

Volumn 39, Issue 3, 2007, Pages 871-877

  Franciosi, Mario ^a   Koff, Walter José ^b   Rhoden, Ernani Luis ^c  

^a UNIVERSITY OF PASSO FUNDO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Benign prostatic hyperplasia; International Prostate Symptom Score (IPSS); Prostate volume; Transitional zone volume of the prostate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; ORGAN WEIGHT; PROSTATE DISEASE; PROSTATE HYPERTROPHY; QUALITY OF LIFE; TRANSRECTAL ULTRASONOGRAPHY;

AGED; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PROSTATE; QUALITY OF LIFE; URINATION DISORDERS;

EID: 34548445131     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-006-9148-8     Document Type: Article

References (27)

1. Shapiro E, Lepor H (1995) Pathophysiology of clinical benign prostatic hyperplasia. Urol Clin North Am 22(2):285-290
2. Issacs JT, Coffey DS (1989) Etiology and disease process of benign prostatic hyperplasia. Prostate 2:33-50
3. Guess HA, Arrighi HM, Metter EJ, Fozard JL (1990) Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate 17(3):241-246
4. Kirby RS (2000) The natural history of benign prostatic hyperplasia: what have we learned in the last decade? Urology 56(5 suppl 1):3-6
5. O'Leary MP (2000) LUTS, ED, QOL: Alphabet soup or real concerns to aging men? Urology 56(5A):7-11
6. Girmam CJ, Jacobsen SJ, Guess HA, Oesterling JE, Chute CG, Panser LA, Lieber MM (1995) Natural history of prostatism: Relationship among symptoms, prostate volume and peak urinary flow rate. J Urol 153:1510-1515
7. Osterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM (1993) Serum prostate specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges. JAMA 270(7):860-864
8. Bosch JL, Kranse HR, Van Mastrigt R, Schröder FH (1995) Reasons for the weak correlation between prostate volume and urethral resistence parameters in patients with prostatism. J Urol 153(3 pt 1):689-693
9. Barry MJ, Cockett AT, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN (1993) Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 150(2 Pt 1): 351-358
10. McNeal JE (1988) The prostate gland: Morphology and pathobiology. Monogr Urol 9:36-41
11. Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett ATK (1992) Measurement Committee of American Urological Association: The American Urological Association symptom index for benign prostate hyperplasia. J Urol 148(5):1549-1557
12. International Consensus Committee (1993) Recommendations of the International Consensus Committee. In: Cockett ATK, Khoury S, Aso Y et al. (eds) Proceedings of the 2nd International Consultation on Benign Prostate Hyperplasia (BPH). Jersey, Channel Islands, Scientific Communication International, p. 556-564
13. Yoshimura K, Arai Y, Ichioka K, Terada N, Matsuta Y, Okubo K (2002) Symptom-specific quality of life in patients with benign prostatic hyperplasia. Int J Urol 9:485-490
14. Desgrandchamps F, Droupy S, Irani J, Saussine C, Comenducci A (2006) Effects of dutasteride on the symptoms of benign prostatic hyperplasia, and patient quality of life and discomfort, in clinical practice. Br J Urol Int 98:83-88
15. Gacci M, Bartoletti R, Figlioli S, Sarti FE, Eisner B, Bodd V, Rizzo M (2003) Urinary symptoms, quality of life and sexual function in patients with benign prostatic hypertrophy before and after prostatectomy: A prospective study. Br J Urol Int 91:196-200
16. Sukov RJ, Scardino PT, Sample WF, Winter J, Confer DJ (1977) Computed tomography and transabdominal ultrasound in the evaluation of the prostate. J Comput Assist Tomogr 1(3):281-289
17. Roehrborn CG, Bartsch G, Kirby R, Andriole G, Boyle P, De La Rosette J, Perrin P, et al (2001) Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: A comparative international overview. Urology 58:642-650
18. Chute CG, Guess HA, Panser LA, Johnson CL, Jacobsen SJ, Oesterling JE, Lieber MM (1993) The non-relationship of urinary symptoms prostate volume and uroflow in a population based sample of men. J Urol 149:356
19. Overland GB, Vatten L, Rhodes T, De Muro C, Jaconbsen G, Vada K, Angelsen A, et al (2001) Lower urinary tract symptom prostate volume and uroflow in Norwegian community men. Eur Urol 39(1):36-41
20. Greene DR, Egawa S, Hellerstein DK, Scardino PT (1990) Sonographic measurements of transition zone of prostate in men with and without benign prostatic hyperplasia. Urology 36(4):293-299
21. Kaplan AS, Te AE, Pressler LB, Olsson CA (1995) Transition zone index as a method of assessing benign prostatic hyperplasia: Correlation with symptoms, urine flow and detrusor pressure. J Urol 154(5):1764-1769
22. Kaplan AS, Reis RB, Staimen VB, Te AE (1998) Is the ratio of transition zone to total prostate volume in their Caucasian Africa-American men than in their Caucasian or hispanic counterparts? Br J Urol 82(6):804-807
23. Caine M, Pfau A, Perlberg S (1976) The use of alpha-adrenergic blockers in benign prostatic obstruction. Br J Urol 48(4):255-263
24. Hutch JA, Rambo ON Jr (1970) A study of the anatomy of the prostate, prostatic urethra and the urinary sphincter system. J Urol 104(3):443-452
25. Grayhack JT, McVary KT, Kozlowski JM (2002) Benign prostatic hyperplasia. In: Gllenwater J, Grayhack JT, Howards S (eds) Adult and pediatric urology. St Louis, Mosby, 2, pp. 1401-1470
26. Gotoh M, Kamihira O, Kinukawa T, Ono Y, Ohshima S, Origasa H (2005) Comparison of tamsulosin and naftopidil for efficacy and safety in the treatment of benign prostatic hyperplasia: A randomized controlled trial. Br J Urol Inter 96(4):581
27. Haltbakk J, Hanestad BR, Hunskaar S (2005) How important are men lower urinary tract symptoms (LUTS) and their impact on the quality of life (QoL). Qual Life Res Sep 14(7):1733-1741